N🟁N

DALLAS--([ BUSINESS WIRE ])--Former United States Securities and Exchange Commission attorney [ Willie Briscoe ] and the securities litigation firm of [ Powers Taylor, LLP ] are investigating the sale of Physicians Formula Holdings, Inc. (aPhysicians Formulaa) (Nasdaq: FACE) to Markwins International Corp. for shareholders. Under the proposed Physicians Formula sale, FACE shareholders will receive only $4.90 in cash for each share of stock owned in a transaction valued at approximately $74.9 million.

"Due in part to the lack of a significant premium, we believe that the transaction may undervalue Physicians Formula stock. Our lawsuit will seek to obtain the highest share price for all shareholders."

If you are an affected investor, and you want to learn more about the lawsuit or join the action, contact Patrick Powers at Powers Taylor, LLP, toll free (877) 728-9607, via e-mail at [ patrick@powerstaylor.com ], or Willie Briscoe at The Briscoe Law Firm, PLLC, (214) 706-9314, or via email at [ WBriscoe@TheBriscoeLawFirm.com ]. There is no cost or fee to you.

The Physicians Formula sale investigation centers on whether Physicians Formula shareholders are receiving adequate compensation for their shares in the buyout, whether the transaction undervalues Physicians Formula stock, and whether Physicians Formulaas board attempted to obtain the highest share price for all shareholders prior to agreeing to the deal. Shareholder rights attorney Willie Briscoe stated that aDue in part to the lack of a significant premium, we believe that the transaction may undervalue Physicians Formula stock. Our lawsuit will seek to obtain the highest share price for all shareholders.a

[ The Briscoe Law Firm, PLLC ] is a full service business litigation and shareholder rights advocacy firm with more than 20 years of experience in complex litigation and transactional matters.

[ Powers Taylor, LLP ] is a boutique litigation law firm that handles a variety of complex business litigation matters, including claims of investor and stockholder fraud, shareholder oppression, shareholder derivative suits, and security class actions.